Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 1
1988 1
1989 5
1990 4
1991 3
1992 8
1993 21
1994 9
1995 12
1996 7
1997 13
1998 12
1999 7
2000 10
2001 6
2002 8
2003 6
2004 10
2005 15
2006 10
2007 14
2008 12
2009 13
2010 11
2011 14
2012 13
2013 16
2014 36
2015 39
2016 50
2017 49
2018 64
2019 66
2020 82
2021 69
2022 40
Text availability
Article attribute
Article type
Publication date

Search Results

667 results
Results by year
Filters applied: . Clear all
Page 1
Risk stratification and medical therapy of pulmonary arterial hypertension.
Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Galiè N, et al. Eur Respir J. 2019 Jan 24;53(1):1801889. doi: 10.1183/13993003.01889-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545971 Free PMC article. Review.
Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplantation may be required in most advanced cases on maximal medical therapy....
Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplant
Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally.
Hakim A, Cooke KR, Pavletic SZ, Khalid M, Williams KM, Hashmi SK. Hakim A, et al. Bone Marrow Transplant. 2019 Mar;54(3):383-392. doi: 10.1038/s41409-018-0266-6. Epub 2018 Jul 23. Bone Marrow Transplant. 2019. PMID: 30038355 Review.
The incidence of bronchiolitis obliterans syndrome (BOS), a devastating manifestation of chronic graft-versus-host-disease, may rise globally due to steady increases in utilization of allogeneic hematopoietic cell transplantation (HCT). Though some advances have occurred i …
The incidence of bronchiolitis obliterans syndrome (BOS), a devastating manifestation of chronic graft-versus-host-disease, may rise globall …
Emerging therapeutic agents for advanced non-small cell lung cancer.
Chen R, Manochakian R, James L, Azzouqa AG, Shi H, Zhang Y, Zhao Y, Zhou K, Lou Y. Chen R, et al. J Hematol Oncol. 2020 May 24;13(1):58. doi: 10.1186/s13045-020-00881-7. J Hematol Oncol. 2020. PMID: 32448366 Free PMC article. Review.
Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with a poor prognosis and no known cure. ...
Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with a poor prognosis and no known cure. . …
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.
Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P. Tambur AR, et al. Am J Transplant. 2018 Jul;18(7):1604-1614. doi: 10.1111/ajt.14752. Epub 2018 May 22. Am J Transplant. 2018. PMID: 29603613 Free article.
The presence of preexisting (memory) or de novo donor-specific HLA antibodies (DSAs) is a known barrier to successful long-term organ transplantation. Yet, despite the fact that laboratory tools and our understanding of histocompatibility have advanced significantly in rec …
The presence of preexisting (memory) or de novo donor-specific HLA antibodies (DSAs) is a known barrier to successful long-term organ tra
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.
Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG, Atluri P, Arabia FA, Cheung A, Holman W, Hoopes C, Jeevanandam V, John R, Jorde UP, Milano CA, Moazami N, Naka Y, Netuka I, Pagani FD, Pamboukian SV, Pinney S, Rogers JG, Selzman CH, Silverstry S, Slaughter M, Stulak J, Teuteberg J, Vierecke J, Schueler S, D'Alessandro DA. Kirklin JK, et al. J Thorac Cardiovasc Surg. 2020 Mar;159(3):865-896. doi: 10.1016/j.jtcvs.2019.12.021. Epub 2020 Jan 23. J Thorac Cardiovasc Surg. 2020. PMID: 31983522 Free article. Review. No abstract available.
Human airway organoid engineering as a step toward lung regeneration and disease modeling.
Tan Q, Choi KM, Sicard D, Tschumperlin DJ. Tan Q, et al. Biomaterials. 2017 Jan;113:118-132. doi: 10.1016/j.biomaterials.2016.10.046. Epub 2016 Oct 28. Biomaterials. 2017. PMID: 27815996 Free PMC article.
Organoids represent both a potentially powerful tool for the study cell-cell interactions within tissue-like environments, and a platform for tissue regenerative approaches. The development of lung tissue-like organoids from human adult-derived cells has not previously bee …
Organoids represent both a potentially powerful tool for the study cell-cell interactions within tissue-like environments, and a platform fo …
Lung transplantation: a comprehensive journey.
D'Cunha J. D'Cunha J. J Thorac Dis. 2021 Nov;13(11):6502-6503. doi: 10.21037/jtd-21-1592. J Thorac Dis. 2021. PMID: 34992829 Free PMC article. No abstract available.
Fungal Infection in Lung Transplantation.
Kennedy CC, Pennington KM, Beam E, Razonable RR. Kennedy CC, et al. Semin Respir Crit Care Med. 2021 Jun;42(3):471-482. doi: 10.1055/s-0041-1729173. Epub 2021 May 24. Semin Respir Crit Care Med. 2021. PMID: 34030208
Invasive fungal infections threaten lung transplant outcomes with high associated morbidity and mortality. ...Trends in fungal infection diagnostic strategies utilize molecular diagnostic methodologies to complement traditional histopathology and culture techniques. While …
Invasive fungal infections threaten lung transplant outcomes with high associated morbidity and mortality. ...Trends in fungal infect …
Frailty and aging-associated syndromes in lung transplant candidates and recipients.
Schaenman JM, Diamond JM, Greenland JR, Gries C, Kennedy CC, Parulekar AD, Rozenberg D, Singer JP, Singer LG, Snyder LD, Bhorade S. Schaenman JM, et al. Am J Transplant. 2021 Jun;21(6):2018-2024. doi: 10.1111/ajt.16439. Epub 2020 Dec 24. Am J Transplant. 2021. PMID: 33296550 Free PMC article. Review.
This manuscript represents the product of the American Society of Transplantation (AST) conference on frailty. Experts in the field reviewed the latest published research on assessment of elderly and frail lung transplant candidates. ...Developing tools for frailty …
This manuscript represents the product of the American Society of Transplantation (AST) conference on frailty. Experts in the field r …
667 results